Evidence map›Paper›PMID 41382955›Full record

ArticleRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie

Severe myelomeningocele in the fourth pregnancy of a 29-year-old woman: a case report.

Liliana Anghelina, Mircea Sebastian Şerbănescu, Cristian Gheonea, Adelina Maria Anghelina, Mirela Anişoara Siminel, Ancuţa Ramona Camen, Anda Lorena Dijmărescu

Abstract readCase Reports
In one paragraph

Article in Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liliana AnghelinaDepartment of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, Romania; mircea_serbanescu@yahoo.com.
Mircea Sebastian Şerbănescu
Cristian Gheonea
Adelina Maria Anghelina
Mirela Anişoara Siminel
Ancuţa Ramona Camen
Anda Lorena Dijmărescu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural tube defects represent a heterogeneous and complex group of congenital abnormalities affecting the central nervous system. These defects occur during embryogenesis as a result of the failure of the neural tube to close completely. A highly clinically significant form is myelomeningocele, often referred to as open spina bifida or spina bifida aperta. Delayed diagnosis presents considerable challenges, and folate deficiency is an important risk factor. This case reports a severe myelomeningocele located in the lumbosacral region of a female neonate, identified at 28-29 weeks' gestation during the only prenatal consultation of a 29-year-old woman who had three previous normal pregnancies and did not take folic acid (FA) supplementation. The delayed diagnosis contributed to the progression of degenerative and traumatic lesions in the neural tissue, leading to the development of Chiari malformation type II and hydrocephalus. These conditions had a profound impact on brain development, significantly increasing the severity of the case. Primary prevention through the periconceptional use of FA supplements has been shown in extensive research to significantly reduce the probability of neural tube defects, including myelomeningocele. For this reason, FA fortification programs as a public health measure have been implemented in many countries.

Indexed as

MeningomyeloceleAdultFemaleHumansInfant, NewbornPregnancycase reportChiari malformation type IIfolic acid supplementationhydrocephalusmyelomeningocele

Identifiers

PMID41382955
PMCPMC12831564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.